LONRF1: A Gene Regulating Cellular Processes and Potential Drug Target

Target Name: LONRF1

NCBI ID: G91694

LONRF1

LONRF1: A Gene Regulating Cellular Processes and Potential Drug Target

LONRF1 (RNF191) is a gene that encodes a protein known as liein (LON-related RNA-facilitating factors) RNA factor 1. LON-related RNA-facilitating factors are a family of proteins that have been identified as key regulators of gene expression and are involved in the control of various cellular processes.

The LONRF1 gene was first identified in 2009 and has since been found to be expressed in a wide range of tissues and cells, including muscle, pancreas, and brain. LONRF1 has also been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and survival.

One of the unique features of LONRF1 is its ability to interact with other proteins, known as RNA-protein interactions, which can lead to the regulation of gene expression. LONRF1 has been shown to interact with several different proteins, including the protein known as TAF100, which is a key regulator of the T-cell receptor (TCR) signaling pathway.

In addition to its role in the regulation of gene expression, LONRF1 has also been shown to play a role in the regulation of cellular signaling pathways. For example, LONRF1 has been shown to be involved in the regulation of the JAK/STAT signaling pathway, which is involved in the regulation of cellular responses to stress and other stimuli.

Given its involvement in a wide range of cellular processes, LONRF1 has generated a lot of interest as a potential drug target or biomarker. Studies have shown that LONRF1 is highly expressed in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In addition, LONRF1 has also been shown to be involved in the regulation of cellular processes that are relevant to the development and progression of diseases. For example, LONRF1 has been shown to be involved in the regulation of the angiogenesis that occurs during the development of cancer.

Furthermore, LONRF1 has also been shown to play a role in the regulation of cellular responses to drugs. Studies have shown that LONRF1 is involved in the regulation of the efficacy of drugs such as chemotherapy and radiation therapy.

In conclusion, LONRF1 is a gene that has been identified as a potential drug target or biomarker due to its involvement in a wide range of cellular processes. Further research is needed to fully understand the role of LONRF1 in the regulation of cellular processes and its potential as a drug target or biomarker.

Protein Name: LON Peptidase N-terminal Domain And Ring Finger 1

The "LONRF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LONRF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets